应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
00719 山东新华制药股份
休市中 04-30 16:08:13
6.190
-0.030
-0.48%
最高
6.220
最低
6.170
成交量
36.40万
今开
6.220
昨收
6.220
日振幅
0.80%
总市值
43.14亿
流通市值
12.07亿
总股本
6.97亿
成交额
224.89万
换手率
0.19%
流通股本
1.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
格隆汇个股放量排行榜 | 5月1日
格隆汇 · 05-01 17:30
格隆汇个股放量排行榜 | 5月1日
山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元
公告速递 · 04-28
山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元
山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元
公告速递 · 04-28
山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元
山东新华制药股份(00719)一季度归母净利润8390.3万元，同比下降25.15%
智通财经 · 04-28
山东新华制药股份(00719)一季度归母净利润8390.3万元，同比下降25.15%
山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书
智通财经 · 04-24
山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
智通财经 · 04-21
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
山东新华制药股份(00719)获得布美他尼注射液药品注册证书
智通财经 · 04-15
山东新华制药股份(00719)获得布美他尼注射液药品注册证书
山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书
智通财经 · 04-07
山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书
市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表
华尔街见闻 · 04-02
市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表
山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》
智通财经 · 04-01
山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》
山东新华制药股份2026年3月无新增发行或股份变动
公告速递 · 04-01
山东新华制药股份2026年3月无新增发行或股份变动
山东新华制药股份(00719)：徐列辞任非执行董事
智通财经 · 03-31
山东新华制药股份(00719)：徐列辞任非执行董事
山东新华制药股份(00719)发布年度业绩 归母净利润2.9亿元 同比减少38.32%
智通财经 · 03-27
山东新华制药股份(00719)发布年度业绩 归母净利润2.9亿元 同比减少38.32%
山东新华制药股份将于日期待公布派发末期股息每股0.15元
公告速递 · 03-27
山东新华制药股份将于日期待公布派发末期股息每股0.15元
智通AH统计|3月25日
智通财经 · 03-25
智通AH统计|3月25日
山东新华制药股份(00719)：新达制药获得布洛芬颗粒药品注册证书
智通财经 · 03-23
山东新华制药股份(00719)：新达制药获得布洛芬颗粒药品注册证书
山东新华制药股份(00719)：依折麦布片获得药品补充申请批准通知书
智通财经 · 03-16
山东新华制药股份(00719)：依折麦布片获得药品补充申请批准通知书
山东新华制药：角逐重磅抗炎镇痛仿制药右酮洛芬氨丁三醇注射液国产第3家，市场潜力大爆发！
摩熵医药 · 03-11
山东新华制药：角逐重磅抗炎镇痛仿制药右酮洛芬氨丁三醇注射液国产第3家，市场潜力大爆发！
每日卖空追踪 | 山东新华制药股份 03月09日卖空量成交2.6万股，卖空比例为4.38%
市场透视 · 03-09
每日卖空追踪 | 山东新华制药股份 03月09日卖空量成交2.6万股，卖空比例为4.38%
每日卖空追踪 | 山东新华制药股份 03月05日卖空量成交2万股，卖空比例为1.94%
市场透视 · 03-05
每日卖空追踪 | 山东新华制药股份 03月05日卖空量成交2万股，卖空比例为1.94%
加载更多
公司概况
公司名称：
山东新华制药股份
所属市场：
SEHK
上市日期：
--
主营业务：
山东新华制药股份有限公司是一家主要从事化学原料药、制剂及化工产品的开发、制造和销售的中国公司。该公司运营三个分部。化学原料药分部主要从事咖啡因系列、布洛芬系列、阿司匹林系列、多巴系列、巴比妥系列及吡哌酸等解热镇痛类原料药的开发、制造及销售。制剂分部主要从事吡哌酸片、安痛定及尼莫地平片等片剂、针剂及胶囊剂等制剂的开发、制造及销售。医药中间体及其他产品分部主要从事医药中间体及其他产品的开发、制造及销售。该公司主要在中国国内市场及美洲和欧洲等海外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":6.19,"timestamp":1777536493002,"preClose":6.22,"halted":0,"volume":364000,"delay":0,"changeRate":-0.004823151125401826,"floatShares":195000000,"shares":697000000,"eps":0.4816251410304626,"marketStatus":"休市中","change":-0.03,"latestTime":"04-30 16:08:13","open":6.22,"high":6.22,"low":6.17,"amount":2248920,"amplitude":0.008039,"askPrice":6.19,"askSize":8000,"bidPrice":6.17,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":0.442577956084681,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":851961600000,"exchange":"SEHK","adjPreClose":6.22,"dividendRate":0.044124,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.5976226438895347,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.08,"timestamp":1777532400000,"preClose":14.26,"halted":0,"volume":4746700,"delay":0,"premium":"-61.66"}},"requestUrl":"/m/hq/s/00719","defaultTab":"news","newsList":[{"id":"2632158966","title":"格隆汇个股放量排行榜 | 5月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632158966","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632158966?lang=zh_cn&edition=full","pubTime":"2026-05-01 17:30","pubTimestamp":1777627804,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日天数智芯(09903)、上海实业控股(00363)、网易-S(09999)、永达汽车(03669)、永利澳门(01128)、中国铁建(01186)、中国信达(01359)、力量发展(01277)、中国光大银行(06818)、汽车街(02443)、中国白银集团(00815)、赛力斯(09927)、太古股份公司A(00019)、中信国际电讯(01883)、华星控股(08","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/01173056970876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01211","00719","02656","00880","00909","02583","02676","00800","00259","06979","09990","02276","02637","00558","06110","00568","00659","00709","02595","00981","00189","09999","00815","09903","02443","02687","01347","00363","02516","00650","01458","02408","02489","02655","00148","06821","06938","00780","00019","09927","00133","01833","02579","00168","00220","01643","00178","01429","00501","01765"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1169278373","title":"山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169278373","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169278373?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:42","pubTimestamp":1777369369,"startTime":"0","endTime":"0","summary":"山东新华制药股份在2025年度实现营业收入87.55亿元人民币，同比上升3.41%；归属于上市公司股东的净利润为2.89亿元，同比下降38.32%，扣除非经常性损益后净利润2.88亿元，降幅为40.10%。基本每股收益0.42元，同比减少39.13%。报告期内经营活动产生的现金流量净额为5.34亿元，同比增长45.19%。分业务板块来看，化学原料药贡献收入26.46亿元，占比约30.22%，制剂业务39.86亿元，占比45.52%，医药中间体及其他约21.24亿元，占比24.26%，形成多元化的营收结构。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"山东新华制药2025年收入同比增长3.41% 归母净利润降至2.89亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195573397","title":"山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195573397","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195573397?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:41","pubTimestamp":1777369287,"startTime":"0","endTime":"0","summary":"本季度信息\n2026年第一季度，山东新华制药股份实现营收24.23亿元，同比下降0.28%。经调整净利润（归属于上市公司股东并扣除非经常性损益后）为0.80亿元，同比下降23.55%。本期经营活动产生的现金流量净额为-1.17亿元，相比去年同期的0.08亿元大幅减少，主要受到营运资金占用等影响。\n从成本结构看，销售费用约1.03亿元，同比微增3.53%；管理费用约0.95亿元，同比上涨0.92%；研发费用约0.95亿元，同比减少13.07%。整体财务指标显示出成本端仍在波动，研发投入维持在较高水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"山东新华制药股份2026年第一季度营收24.23亿元，经调整净利润0.80亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630741043","title":"山东新华制药股份(00719)一季度归母净利润8390.3万元，同比下降25.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630741043","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630741043?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:39","pubTimestamp":1777369170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，2026年第一季度，营业收入24.23亿元，同比下降0.28%;归属于上市公司股东的净利润8390.3万元，同比下降25.15%;基本每股收益0.12元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629735816","title":"山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2629735816","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629735816?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:35","pubTimestamp":1777019735,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的氯化钾颗粒《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。2026年3月，新华制药向国家药品监督管理局递交上市许可持有人变更的补充申请资料并获得受理，2026年4月获得药品补充申请批准通知书，审评结论为：本品持有人转让申请符合药品上市后变更管理的有关要求，批准本品上市许可持有人变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)：氯化钾颗粒获得药品补充申请批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772986","title":"智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629772986?lang=zh_cn&edition=full","pubTime":"2026-04-21 07:28","pubTimestamp":1776727718,"startTime":"0","endTime":"0","summary":"根据2026年4月20日询价申购情况，初步确定的本次询价转让价格为410.34元/股。本次询价转让不通过集中竞价交易方式或大宗交易方式进行，不属于通过二级市场减持。受让方通过询价转让受让的股份，在受让后6个月内不得转让。截至收盘，暗盘交易显示报价333港元，较招股价209.88港元上涨58.66%，每手100股，不计手续费，每手赚12312港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bd99c7d8869305150ea2122170bfd90e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNFRY","LU0823437842.USD","00719","SG9999002463.SGD","SG9999000327.SGD","601607","LU1934453819.USD","LU0611395673.USD","LU2476274308.USD","LU0251143458.SGD","BK4526","LU0651947912.USD","IE0008368742.USD","LU0543330483.HKD","00941","INTC","LU1064130708.USD","LU0516423174.USD","LU0469268626.HKD","02607","LU1770034418.SGD","LU0259732245.USD","600941","BK1191","LU0132412106.USD","LU0505663152.USD","LU1820825898.SGD","LU2041044095.USD","LU1251922891.USD","00451","LU0359201612.USD","LU0502904849.HKD","IE0032431581.USD","LU0049853897.USD","LU0048388663.USD","01093","LU1226287529.USD","LU0124384867.USD","LU1993786604.SGD","LU0370786039.SGD","LU2153592121.USD","LU0405327494.USD","LU0828237940.HKD","LU0188438112.USD","000756","LU0048575426.USD","SG9999002828.SGD","LU1102505929.USD","LU1008478684.HKD","LU1188198961.HKD","LU0593848301.USD","BK1521","LU0607220059.USD","LU0650527681.SGD","SG9999004220.SGD","LU0405327148.USD","LU0315179316.USD","LU2249611893.SGD","LU1769817179.HKD","LU2289578879.USD","LU2506952337.HKD","SGXZ49509284.SGD","LU0302445910.USD","LU0509642566.USD","LU1064131003.USD","LU0314109678.HKD","LU2039709279.SGD","LU2097828805.USD","603093","LU1226288170.HKD","SG9999001903.USD","LU0823414478.USD","LU1831875114.USD","LU0107464264.USD","LU1146622755.USD","LU1515016050.SGD","LU1226287792.SGD","LU1242518931.SGD","LU0880133367.SGD","LU1580142542.USD","SG9999003461.SGD","LU0043850808.USD","LU0128522157.USD","LU2778985437.USD","LU2242644610.SGD","LU2495084118.USD","SHPMY","LU2092937221.SGD","LU0165289439.USD","LU0326948709.USD","LU2097828557.USD","LU1303224171.USD","LU2148510915.USD","LU0348805143.USD","LU0235996351.USD","IE00B031HY20.USD","LU1861214812.USD","LU0516422366.SGD","LU1152091168.USD","BK1129","LU1813983027.USD","LU0449509016.USD","IE0003795394.USD","LU0047713382.USD","LU0214875030.USD","LU1769817096.USD","LU0143863198.USD","LU1102505762.USD","02691","03983","LU1939255532.USD","LU1152091754.HKD","LU1951186391.HKD","LU2357125470.USD","LU0823426480.USD","LU1880383440.USD","LU2153591404.USD","LU0456827905.SGD","LU0051755006.USD","LU0516423091.SGD","LU0164872284.USD","LU0106252389.USD","LU2097828714.EUR","LU2125910500.SGD","LU2348774022.SGD","LU0979878070.USD","LU1969619763.USD","LU2449936058.SGD","LU1961090484.USD","IE00B8HQ1Z84.USD","LU0210526637.USD","LU0531970944.HKD","LU1226287875.USD","LU2298321311.HKD","LU2506951792.HKD","IE00B29SXG58.USD","IE00BZ08YT58.USD","IE00BZ199S13.USD","LU2394011477.USD","LU2506952410.USD","LU0672654166.SGD","LU0106959298.USD","LU1868838027.USD","LU0871576103.HKD","LU0244354667.USD","LU0164865239.USD","LU1781817850.SGD","BK1147","LU2580892789.USD","LU1048596156.SGD","IE0008369823.USD","LU0048580855.USD","LU0821914370.USD","IE0003851619.USD","LU1023057109.AUD","SG9999001689.USD","LU0516422952.EUR","PLUG","IE00BD6J9T35.USD","BK4588","HK0000181138.USD","LU1794554557.SGD","LU0359202008.SGD","LU0149534421.HKD","LU1721428347.USD","IE00B8L5B284.USD","LU0192582467.USD","LU0181495838.USD","LU0463099449.HKD","300750","LU1328277881.USD","LU2348773727.SGD","LU2477742899.HKD","LU2506952253.HKD","BK1515","LU0011963245.USD","LU0106259558.USD","LU0327786744.USD","LU0572944931.SGD","LU2275660780.HKD","LU2476274720.SGD","BK4585","LU0828238088.HKD","LU1807302812.USD","02575","LU2097828631.EUR","EVS.SI","IE00B3M56506.USD","LU0449515922.USD","LU2125910849.SGD","LU0516422440.USD","LU0312595415.SGD","LU0328353924.USD","META","LU0228659784.USD","03393","BK0224","BK1154","LU1051769294.HKD","SG9999000459.SGD","LU0605514214.HKD","09696","LU1226288253.USD","300476","LU0501845795.SGD","LU2097828474.EUR","LU0254981946.USD","LU1997245094.SGD","LU1719994722.HKD","LU1242518857.USD","03200","SG9999001846.SGD","BK1554","LU2294711713.HKD","LU2298064838.USD","LU0320764755.SGD","LU2424517915.HKD","LU0823426308.USD","LU1255011170.USD","LU1720050803.USD","02476","LU0143863784.USD","LU0067412154.USD","LU0140636845.USD","LU0823414551.USD","LU2294711473.HKD","HK0000181112.HKD","LU0359201885.HKD","LU2328871848.SGD","BK4141","BK1610","CBLUY","06608","LU0261950470.USD","LU2152927971.USD","LU0724618433.USD","LU2298322129.HKD","LU2580892862.HKD","IE00BZ08YR35.GBP","LU0594300419.USD","LU2399975544.HKD","LU0029875118.USD","002466","LU0531971595.HKD","SG9999014674.SGD","01866","TSLA","LU1808992512.USD","LU2045819591.USD","04335","BK4519","LU3063872942.SGD","LU0326950275.SGD","LU1868837565.USD","SGXZ81163826.USD","IE00B5MMRT66.SGD","LU2360108059.USD","IE00BPRC5H50.USD","LU1039395188.USD","LU1051768304.USD","LU1979443071.USD","LU2360107325.USD","LU1880383366.USD","LU0039217434.USD","BK1116","LU0231483743.USD","LU0072913022.USD","LU0594300179.USD","LU0828237510.HKD","IE00BZ08YS42.EUR","LU1960683339.HKD","301200","LU1997244956.HKD","00297","LU0054450605.USD","LU0651946864.USD","LU0455707207.USD","HK0000165453.HKD","LU1997245177.USD","LU1861219969.SGD","COIN","03750","BK1594","LU1655091616.SGD","LU1978683503.SGD","LU2238339852.HKD","IE00B543WZ88.USD","LU0072462343.USD","LU1048588211.SGD","LU0269904917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627402897","title":"山东新华制药股份(00719)获得布美他尼注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627402897","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627402897?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:34","pubTimestamp":1776242083,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的布美他尼注射液《药品注册证书》。2026年4月，新华制药获得布美他尼注射液《药品注册证书》，审评结论为批准注册。布美他尼注射液属于《国家基本医疗保险、工伤保险和生育保险药品目录》乙类品种。根据相关统计数据，2024年中国公立医疗机构布美他尼注射液销售额约为人民币4.7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得布美他尼注射液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625193227","title":"山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2625193227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625193227?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:17","pubTimestamp":1775560662,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的钠钾镁钙注射用浓溶液《药品注册证书》。2024年6月，北京民康百草医药科技有限公司向国家药品监督管理局药品审评中心递交了钠钾镁钙注射用浓溶液上市许可注册申报资料并获受理。新华制药的钠钾镁钙注射用浓溶液于2026年4月取得药品注册证书，有利于丰富公司制剂产品系列，提高竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得钠钾镁钙注射用浓溶液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624579462","title":"市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表","url":"https://stock-news.laohu8.com/highlight/detail?id=2624579462","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624579462?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:06","pubTimestamp":1775117205,"startTime":"0","endTime":"0","summary":"相信光的力量？","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3769090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01879","COHR","00719","000756","BK4535","BIDU","TCEHY","00700","LITE","BK4588","09888","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624359514","title":"山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624359514","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624359514?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:38","pubTimestamp":1775032680,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，公司收到国家药品监督管理局核准签发的人工牛黄甲硝唑胶囊《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。2026年3月，新华制药向国家药品监督管理局递交上市许可持有人变更的补充申请资料并获得受理，近日获得药品补充申请批准通知书，审评结论为：本品持有人转让申请符合药品上市后变更管理的有关要求，批准本品上市许可持有人变更。本品适用于急性智齿冠周炎，局部牙槽脓肿、牙髓炎、根尖周炎等。根据相关统计数据，2024年中国公立医疗机构人工牛黄甲硝唑胶囊销售额约为人民币5.79亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)：人工牛黄甲硝唑胶囊获得《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147752343","title":"山东新华制药股份2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1147752343","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147752343?lang=zh_cn&edition=full","pubTime":"2026-04-01 08:26","pubTimestamp":1775003183,"startTime":"0","endTime":"0","summary":"山东新华制药股份有限公司于2026年4月1日发布2026年3月股份变动月报表。公告显示，截至2026年3月31日，公司总股本继续保持稳定，未发生新增发行、购回或注销等活动。\n报告期内，H股已发行数量为195,000,000股，A股已发行数量为501,683,435股，两者均与上月末持平，合计注册股本为696,683,435股。公司在期权与激励计划方面无行权或失效事项，1,155,000股期权全部维持至报告期末。\n公告同时确认遵守香港联交所《上市规则》及相关法规，所有已发行股份合规合法，无任何库存股份变动。该公告由公司秘书曹长求签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304499","title":"山东新华制药股份(00719)：徐列辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304499","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623304499?lang=zh_cn&edition=full","pubTime":"2026-03-31 16:50","pubTimestamp":1774947033,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，公司非执行董事徐列先生因达退休年龄辞任公司董事以及董事会发展战略委员会成员职务。该辞任自2026年3月31日起生效，之后徐先生在公司已无担任任何职位及职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","00719","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622415898","title":"山东新华制药股份(00719)发布年度业绩 归母净利润2.9亿元 同比减少38.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622415898","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622415898?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:50","pubTimestamp":1774601434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布截至2025年12月31日止年度业绩，营业收入87.55亿元，同比增加3.41%;归母净利润2.9亿元，同比减少38.32%;基本每股收益0.42元;拟派发末期股息每股0.15元。公告称，全年取得药品批件47个，创历史新高。充分发挥塬料药综合优势，国内销售收入保持稳定增长，布洛芬、卡巴匹林钙等重点产品国内市占率进一步扩大。特色塬料药美洛昔康、格列美脲、碳酸司维拉姆出口销量同比大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173521592","title":"山东新华制药股份将于日期待公布派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173521592","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173521592?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:47","pubTimestamp":1774601259,"startTime":"0","endTime":"0","summary":"山东新华制药股份(00719)于2026年3月27日公告，董事会就截至2025年12月31日止财政年度宣派末期股息每股人民币0.15元。该股息尚待股东批准，具体除净日、股权登记日及派息日等信息均有待公布。\n根据公告，股份过户登记相关手续和派发金额的汇率亦将另行披露。公司现任董事会成员包括执行董事贺同庆（董事长）、徐文辉、侯宁，非执行董事徐列、张成勇，以及独立非执行董事潘广成、朱建伟、凌沛学和张菁菁。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622023791","title":"智通AH统计|3月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2622023791","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622023791?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:15","pubTimestamp":1774426506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止3月25日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为493.41%、325.36%、276.27%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-26.57%、-18.19%、-3.98%。其中绿色动力环保、新天绿色能源、中国能源建设的偏离值位居前三，分别为57.67%、39.10%、34.22%；另外，东北电气、山东墨龙、京城机电股份的偏离值位居后三，分别为-82.52%、-74.54%、-54.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00042","02359","00347","LU0417516738.SGD","LU0918141887.USD","HK0000352291.HKD","03986","01330","03369","LU0469268626.HKD","00338","03968","02865","00916","03750","LU0315179316.USD","LU2039709279.SGD","LU1688375341.USD","01033","LU1719994722.HKD","LU2097828474.EUR","02880","BK1535","06031","01812","399300","00956","LU2242644610.SGD","00300","00187","01057","LU1282649067.USD","00719","02218","00553","02768","00588","02338","LU0828237510.HKD","03678","LU0449515922.USD","159982","03200","IE00BMCWC346.EUR","03143","03996"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621329776","title":"山东新华制药股份(00719)：新达制药获得布洛芬颗粒药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2621329776","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621329776?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:41","pubTimestamp":1774255302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司之全资子公司山东淄博新达制药有限公司收到国家药品监督管理局核准签发的布洛芬颗粒《药品注册证书》。2023年12月，新达制药向国家药品监督管理局药品审评中心递交布洛芬颗粒上市许可注册申报资料并获受理，2026年3月获得《药品注册证书》，审评结论为批准注册。布洛芬颗粒是《国家基本医疗保险、工伤保险和生育保险药品目录》乙类品种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1574","BK1515","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619045679","title":"山东新华制药股份(00719)：依折麦布片获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2619045679","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619045679?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:37","pubTimestamp":1773653876,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份 发布公告，近日，山东新华制药股份有限公司收到国家药品监督管理局核准签发的依折麦布片《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。2026年2月，新华制药向国家药品监督管理局递交上市许可持有人变更的补充申请资料并获得受理，2026年3月获得药品补充申请批准通知书，审评结论为：本品持有人转让申请符合药品上市后变更管理的有关要求，批准本品上市许可持有人变更。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00719","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618890974","title":"山东新华制药：角逐重磅抗炎镇痛仿制药右酮洛芬氨丁三醇注射液国产第3家，市场潜力大爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2618890974","media":"摩熵医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618890974?lang=zh_cn&edition=full","pubTime":"2026-03-11 11:38","pubTimestamp":1773200314,"startTime":"0","endTime":"0","summary":"3月10日，据CDE官网显示，山东新华制药提交的3类仿制药右酮洛芬氨丁三醇注射液的上市申请获受理。目前，该品种仅有2家药企成功获批并过评，若山东新华制药此次能顺利突围，将有望斩获国产第3家。短短两年间，市场快速放量：摩熵医药数据库显示，2025年前三季度，右酮洛芬氨丁三醇注射液在全终端医院销售额超3亿元，同比暴增270.11%，成为围术期镇痛领域增速最快的品种之一，市场潜力可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311113858a6b6f0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311113858a6b6f0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618059056","title":"每日卖空追踪 | 山东新华制药股份 03月09日卖空量成交2.6万股，卖空比例为4.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618059056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618059056?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045015,"startTime":"0","endTime":"0","summary":"山东新华制药股份北京时间03月09日，跌0.89%，卖空量成交2.6万股，较上一交易日增加62.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163125a6b1c4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163125a6b1c4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00719","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617004514","title":"每日卖空追踪 | 山东新华制药股份 03月05日卖空量成交2万股，卖空比例为1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617004514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617004514?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699415,"startTime":"0","endTime":"0","summary":"山东新华制药股份北京时间03月05日，涨0.3%，卖空量成交2万股，较上一交易日减少85.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163125a44ef4d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163125a44ef4d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xhzy.com","stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0283},{"period":"3month","weight":-0.1182},{"period":"6month","weight":-0.1094},{"period":"1year","weight":0.177},{"period":"ytd","weight":-0.0607}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东新华制药股份有限公司是一家主要从事化学原料药、制剂及化工产品的开发、制造和销售的中国公司。该公司运营三个分部。化学原料药分部主要从事咖啡因系列、布洛芬系列、阿司匹林系列、多巴系列、巴比妥系列及吡哌酸等解热镇痛类原料药的开发、制造及销售。制剂分部主要从事吡哌酸片、安痛定及尼莫地平片等片剂、针剂及胶囊剂等制剂的开发、制造及销售。医药中间体及其他产品分部主要从事医药中间体及其他产品的开发、制造及销售。该公司主要在中国国内市场及美洲和欧洲等海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.012276},{"month":2,"riseRate":0.766667,"avgChangeRate":0.099858},{"month":3,"riseRate":0.433333,"avgChangeRate":-0.00788},{"month":4,"riseRate":0.7,"avgChangeRate":0.100968},{"month":5,"riseRate":0.344828,"avgChangeRate":0},{"month":6,"riseRate":0.448276,"avgChangeRate":-0.003358},{"month":7,"riseRate":0.586207,"avgChangeRate":0.015918},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.041915},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.018334},{"month":10,"riseRate":0.448276,"avgChangeRate":0.008832},{"month":11,"riseRate":0.551724,"avgChangeRate":0.012328},{"month":12,"riseRate":0.586207,"avgChangeRate":0.023867}],"exchange":"SEHK","name":"山东新华制药股份","nameEN":"SHANDONG XINHUA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山东新华制药股份,00719,山东新华制药股份股票,山东新华制药股份股票老虎,山东新华制药股份股票老虎国际,山东新华制药股份行情,山东新华制药股份股票行情,山东新华制药股份股价,山东新华制药股份股市,山东新华制药股份股票价格,山东新华制药股份股票交易,山东新华制药股份股票购买,山东新华制药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山东新华制药股份(00719)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山东新华制药股份(00719)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}